Page 57 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. Charles River Partners with JADE Biomedical to Expand Biologics Capabilities January 14, 2021 GMT WILMINGTON, Mass. & SHANGHAI--(BUSINESS WIRE)--Jan 14, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management services for the biopharmaceutical industry. The...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides ... Artelo BiosciencesJanuary 14, 2021 GMT Received Clinical Trial Authorization to Commence Cancer Appetite Recovery Phase I/II Clinical Study of ART27.13 in UK Awarded Mitacs Accelerate Grant LA JOLLA, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.  (NASDAQ: ARTL), a clinical stage biopharm...

DUBLIN--(BUSINESS WIRE)--Jan 14, 2021--

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from PR Newswire. The AP news staff was not involved in its creation. Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories January 12, 2021 GMT MONTREAL, Jan. 12, 2021 /PRNewswire/ - Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners (“Arsenal”), announced today the acquisition of Mosaic Laboratories LLC (“Mosaic”), a California-based company of...

DUBLIN--(BUSINESS WIRE)--Jan 13, 2021--

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of ... Oxford Immunotec Global PLCJanuary 13, 2021 GMT OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announce the start of a collaboration with Valneva. The Company will perf...

Press release content from Accesswire. The AP news staff was not involved in its creation. Jaguar Health Enters Non-dilutive Binding Term Sheet for $6.0 Million Sale of Partial Rights to Possible Tropical Disease Priority Review Voucher January 13, 2021 GMT This additional non-dilutive financing will support development program for lechlemer for the indication of the symptomatic relief of diarrhea and dehydration in cholera patients REMINDER: Jaguar-hosted investor webcast scheduled for Thursda...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Health Canada approves Lundbeck’s (Pr)VYEPTI® (eptinezumab)--the first and only intravenous preventive treatment for migraine January 12, 2021 GMT Lundbeck Canada Inc. Logo (CNW Group/Lundbeck Canada Inc.) MONTREAL, Jan. 12, 2021 /PRNewswire/ - Lundbeck is pleased to announce that VYEPTI® (eptinezumab) has been approved by Health Canada for the preventive treatment of migraine in adults who have at l...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and ... Merus N.V.January 12, 2021 GMT UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced collaborations with nat...